Brief: Nextcell Pharma Q4 Operating Income SEK 2.5 Mln
30/10/2025 06:38
Oct 30 (Reuters) - NextCell Pharma AB NXTCL.ST: Q4 OPERATING INCOME AMOUNTED TO 2,522 (1,696) THOUSAND SEK, OF WHICH CELLAVIVA ACCOUNTED FOR 2,600 (1,643) THOUSAND SEK Q4 NET SALES AMOUNTED TO 2,600 (1,643) THOUSAND SEK Q4 PROFIT AFTER FINANCIAL ITEMS AMOUNTED TO -8,481 (-13,249) THOUSAND SEK Source text: ID:nWkr70B5Q5 Further company coverage: NXTCL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln